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Delayed Lymphoid Repopulation with
Defects in IL-4±Driven Responses
Produced by Inactivation of NF-ATc
et al., 1994, 1995b; Cockerill et al., 1995). NF-AT is ex-
pressed in B as well as T lymphocytes. In transgenic
mice, a reporter driven by the IL-2 NF-AT/AP-1 element
is expressed at its highest levels in activated T and B
cells (Verweij et al., 1990). In B cells, ligation of the
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receptor (TCR), translocates into the nucleus. In the nu-
cleus, NF-AT associates with an inducible nuclear com-
ponent composed of AP-1 family member proteins (Jain
Summary et al., 1992, 1993; Boise et al., 1993; Rooney et al., 1995a,
1995b). Nuclear translocation of NF-AT is controlled by
The NF-AT family of transcription factors activates the calcium-regulated phosphatase calcineurin, which
early immune response genes such as cytokines. In is a target for the immunosuppressive drugs cyclosporin
the adult, NF-ATc is expressed exclusively in the A (CsA) and FK506 (Flanagan et al., 1991; Clipstone and
lymphoid system and is induced upon lymphocyte ac- Crabtree, 1992; Beals et al., 1997). Treatment of T cells
tivation. NF-ATc null mutant mice die in utero of car- with CsA or FK506 prevents nuclear translocation of NF-
diac failure, precluding analysis of the role of NF-ATc AT and subsequent activation of cytokine gene tran-
in lymphocyte activation. By using RAG-2±deficient scription (Emmel et al., 1989).
blastocyst complementation, we now demonstrate Purification of proteins that bound to NF-AT target
sequences in the IL-2 promoter led to the isolation ofthat young, highly chimeric mice lacking NF-ATc have
two distinct genes, called NF-ATc (also called NF-ATc1)impaired repopulation of both thymus and peripheral
and NF-ATp (also called NF-ATc2), that were highly ho-lymphoid organs. Furthermore, NF-ATc deficiency im-
mologous within a region distantly related to the Relpaired T lymphocyte activation and secretion of IL-4.
domain (McCaffrey et al., 1993; Northrop et al., 1994).B lymphocytes displayed reduced proliferation and a
Subsequently, two other NF-AT genes, NF-AT3 (NF-selective loss of IL-4±driven immunoglobulin isotypes
ATc4) and NF-AT4 (NF-ATx or NF-ATc3), were isolatedboth in vivo and in vitro. Our data demonstrate that
by low-stringency cross-hybridization with the Rel do-NF-ATc is essential for the optimal generation and
main and proved to have 65% identity to NF-ATp andfunction of mature T and B lineage cells, with an espe-
NF-ATc (Hoey et al., 1995; Masuda et al., 1995). Whilecially profound effect on IL-4±driven responses.
all four NF-AT proteins can bind to and transactivate
the promoters of multiple cytokine genes, the tissue
distribution and inducibility upon T cell activation ofIntroduction
these proteins differ, raising the possibility that their
functions might be distinct.Nuclear factor of activated T cells (NF-AT) was first iden-
As an approach to addressing this issue we have
tified as a transcriptional regulatory complex important
produced strains of mice with targeted disruptions in
for the expression of the T cell cytokine interleukin-2
the NF-ATp, NF-AT4, and NF-ATc loci. Mice lacking NF-
(IL-2) (Durand et al., 1988; Shaw et al., 1988; Crabtree, ATp displayed unbalanced transcription of the IL-4 gene
1989; Rao et al., 1997). More recently, NF-AT target during the course of an immune response, with a shift
sequences have been identified in the promoters of to T helper 2 (Th2)±type cytokines (Hodge et al., 1996;
multiple cytokine genes expressed in T cells, including Xanthoudakis et al., 1996). Furthermore, though devel-
IL-4, granulocyte-macrophage colony-stimulating fac- opmentally normal, NF-ATp±deficient mice manifested
tor (GM-CSF), IL-3, and tumor necrosis factor a (Del an unexpected phenotype of splenomegaly and hyper-
Prete et al., 1991; Miyatake et al., 1991; Chuvpilo et al., proliferation of lymphoid cells (Hodge et al., 1996; Xan-
1993; Goldfeld et al., 1993; Masuda et al., 1993; Rooney thoudakis et al.,1996). A defect in induction of theCD40L
and Fas ligand (FasL) receptors was also noted in these
animals and is consistent with the demonstrated pres-
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each other in controlling gene expression, demonstra- It is noteworthy that no NF-ATc mutant protein could
be detected in embryonic heart tissue of the homozy-ting at least some nonoverlapping functions for NF-AT
proteins. gous deficient mice by immunohistochemistry and con-
focal microscopy (Ranger et al., 1997), a technique moreTo examine the function of NF-ATc in the immune
system, we used the RAG-2±deficient blastocyst com- sensitive than Western blot analysis, suggesting that
the NF-ATc gene may be transcribed differently or mayplementation system (Chen et al., 1993). Our data dem-
onstrate complementary, cytokine-selective functions be subject to differential posttranslational stability in
distinct tissues. This is consistent with the presence offor NF-AT family members.
distinct isoforms of NF-ATc in different tissues (Park et
al., 1996; Lyakh et al., 1997).Results and Discussion
Generation of NF-ATc2/2RAG-22/2
Delayed Lymphoid Repopulation inLymphoid Chimeras
NF-ATc2/2RAG-22/2 ChimerasTo assess NF-ATc function in the immune system, we
Seven chimeric mice, aged 10±22 weeks, were analyzed.introduced a null mutation into both alleles of the NF-
In four animals, a marked deficiency in numbers of thy-ATc gene using homologous recombination (Figure 1A).
mocytes and peripheral lymph node (LN) and splenicTwo different targeting constructs containing either the
lymphocytes was observed (Table 1). Interestingly, inneomycin or hygromycin drug-resistance genes were
the five mice aged 10±14 weeks, an inverse correlationused sequentially to replace a region of the NF-ATc
between the degree of chimerism in nonlymphoid or-gene encoding the DNA-binding domain (amino acids
gans and the extent of lymphoid reconstitution was ap-635±653). NF-ATc±deficient embryonic stem (ES) cells
parent (Figure 1F). The more highly chimeric the animal,containing homozygous mutations (Figure 1B) were
the more severe was the lymphopenia. In the two miceinjected into RAG-22/2 blastocysts to produce NF-
aged 17 and 22 weeks, reconstitution was normal de-ATc2/2RAG-22/2 chimeric mice (Chen et al., 1993). The
spite good chimerism. This finding suggests that themice included in our analyses displayed significant (at
presence of NF-ATc in a nonlymphoid cell, possibly aleast 20%) contributions of the NF-ATc2/2 ES cells to
macrophage, dendritic, or stromal cell, is necessary formultiple tissues, as assessed by Southern blot analysis
optimal and timely lymphoid reconstitution: thus, the(Figure 1B). The lymphoid compartment of such mice is
defect in lymphopoiesis is only partly cell autonomous.composed exclusively of cells derived from the ES do-
Indeed, NF-ATc is present in Mac-11 cells and RAG-nor, thus allowing us to examine the role of NF-ATc in
22/2 spleen cells (Timmerman et al., 1997 and data notthe immune system.
shown). In the absence of NF-ATc, reconstitution of theImmunoblot analysis of ionomycin-stimulated splenic
lymphoid compartments is delayed but not completelyT cells from wild-type (wt) mice and 2/2 chimeras and
blocked. Overall, these data demonstrate that NF-ATctransformed pre-B cells (data not shown) using a mono-
is required for the optimal generation of thymocytes andclonal antibody (mAb) specific for NF-ATc revealed three
subsequent seeding of the peripheral lymphoid com-full-length NF-ATc polypeptides, as shown previously
partment.(Dolmetsch et al., 1997) (Figure 1C). These full-length
In all hypoplastic chimeric thymi, an increased numberpolypeptides are absent in 2/2 extracts, but three
of double-negative (DN) thymocytes was seen (Figuresmaller polypeptides reactive with the NF-ATc mAb
2A). However, further analysis revealed these cells towere detected, although at approximately 5-fold lower
be Ly9.12CD251CD442, consistent with their origin fromamounts than the wt protein. The size of the mutant
the RAG-22/2 blastocyst rather than from NF-ATc2/2polypeptides is consistent with a mutant protein lacking
ES cells. This modest increase in DN cells was usuallyamino acids 635±710 at the C terminus, as predicted
accompanied by a concomitant modest decrease in DPfrom the targeting construct. Electromobility shift assays
thymocytes and normal ratios of CD4 and CD8 single-(EMSAs) of nuclear extracts prepared from transformed
positive cells (Figure 2A). Levels of transcripts encodingB cells from wt or NF-ATc2/2 mice revealed an absence
NF-ATc are higher than those for NF-ATp and NF-AT4of NF-ATc DNA binding activity, as detected by su-
in DN thymocytes, consistent with these findings (Oukkapershift analysisusing a mAb specific for NF-ATc (Figure
et al., submitted). We conclude that NF-ATc is not re-1D). We also expressed a recombinant polypeptide cor-
quired for developmental programs in the thymus, al-responding to the Rel domain of themutant allele, gener-
though in its absence, reconstitution is quantitativelyated from NF-ATc cDNA from 2/2 cells (Figure 1E, left).
impaired.EMSA performed with the mutant and corresponding wt
Although total numbers of splenic and LN T and Brecombinant polypeptides demonstrated that the mu-
cells were markedly reduced in some NF-ATc2/2RAG-tant protein did not bind an NF-AT target sequence even
22/2 mice (Table 1), the spleen and LN at all times con-at a 30-fold excess compared to wt protein (Figure 1E,
tained normal proportions of T and B cells as well asright).
the expected ratio of CD41 and CD81 T cells (FigureThus, the mutant NF-ATc protein is unable to bind to
2B). The expression of a range of T cell surface recep-DNA and, furthermore, should not function as a domi-
tors and differentiation markers, including CD3, CD5,nant negative since a minimum 10-fold excess of NF-
CD40L, CD45RB, CD44, and CD25, was normal (dataATc dominant negative mutant relative to wt protein has
not shown). B cell development was also largely undis-been shown to be required (Northrop et al., 1994). This
turbed in the absence of NF-ATc, as assessed by thealteration of the NF-ATc gene is therefore a loss-of-
function mutation and will be referred to as null. equivalent coexpression of B220, immunoglobulin M
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Figure 1. Targeted Disruption of the NF-ATc Gene
(A) Schematic representation of the NF-ATc targeting constructs. The intron±exon structure of the 39 terminus of genomic DNA encoding a
portion of the NF-ATc Rel similarity domain (RHD) isolated from a 129/Sv genomic library (top). Replacement construct containing the HSV-
tk and neomycin-resistance (neo) genes both under the control of the mouse phosphoglycerate kinase (PGK) promoter indicating the replace-
ment of the RHD (amino acids 635±653) with neo (middle). Replacement construct containing the HSV-tk and hygromycin-resistance genes
(hygro) under the control of the PGK promoter indicating the replacement of the RHD (amino acids 635±653) with hygro (bottom). Crosses
indicate the area predicted to undergo replacement. Probes and restriction sites used for diagnostic Southern blotting: AS, Asp718; B, BamHI;
E, EcoRI; H, HindIII; N, NdeI; P, PstI; S, SalI; Sc, SacI; X, XhoI.
(B) Southern blot analysis of the NF-ATc homozygous (2/2) mutant ES cell clone and analysis of the contribution of the NF-ATc2/2 ES cells
to different tissues in adult NF-ATc2/2RAG-22/2 chimeric mice. The Southern blot was probed with the 39 NF-ATc probe, which detects the
wt and targeted NF-ATc alleles. Arrows indicate replacement of the 13 kb wt fragment with the 8.5 kb neo targeted allele and the 7.9 kb hygro
targeted allele.
(C) Western blot analysis with an NF-ATc±specific mAb (7A6). Extracts from wt (1/1) and NF-ATc2/2 ionomycin-stimulated spleen T cells.
Arrows indicate the positions of the molecular mass markers (in kilodaltons) and the location of the NF-ATc isoforms. (D) EMSA comparing
the DNA-binding activites of the wt and mutant NF-ATc proteins in nuclear extracts prepared from Abelson virus±transformed wt and 2/2
pre-B cell lines. A mAb to NF-ATc (7A6) was used to supershift the complexes observed. The position of the NF-ATc complex is indicated.
(E) EMSA comparing the DNA-binding activity of recombinant wt and mutant NF-ATc proteins. Autoradiogram (left) showing expression of
Rel domain polypeptides from wt (amino acids 408±710) or mutant (amino acids 408±634) NF-ATc genes. The proteins were expressed in an
in vitro transcription±translation extract and labeled with 35S. The positions of the molecular mass size markers are indicated in kilodaltons
to the left of the gel. wt or mutant proteins were tested by EMSA (right) for DNA binding using as a probe a labeled sequence corresponding
to the distal NF-AT site from the murine IL-4 promoter (59-TACATTGGAAAATTTTATTACAC-39). Reactions in lanes 1±3 and 4±6 were carried
out with 0.3, 1, and 3 ml of the wt and mutant NF-ATc Rel domain polypeptides, respectively.
(F) Comparison of chimerism and lymphoid reconstitution in NF-ATc2/2RAG-22/2 chimeras. Percentage reconstitution is calculated as (number
of 2/2 splenocytes)/(number of wt splenocytes) 3 100. Percentage chimerism is presented as (density of 2/2 bands)/(density of 1/1 bands)
3 100 and was established by densitometric analysis of Southern blots from at least three nonimmune system organs. Each point corresponds
to an individual chimeric mouse (aged 10±14 weeks).
Immunity
128
Table 1. Lymphoid Repopulation in NF-ATc2/2 Chimeras
No. of Cells 3 106
Age (weeks) Genotype Thymus Spleen Lymph Node
10 wt 67 77 17
NF-ATc2/2 14 17 4
RAG-22/2 3 28 0
11 wt 95 49 24
NF-ATc2/2 26 26 19
RAG-22/2 2 3 Ð
12 wt 109 171 16
NF-ATc2/2 3 30 2
RAG-22/2 Ð 20 Ð
12 wt 80 37 23
NF-ATc2/2 90 41 25
RAG-22/2 Ð 16 Ð
14 wt 92 79 19
NF-ATc2/2 31 31 21
RAG-22/2 0.7 29 Ð
17 wt 86 53 15
NF-ATc2/2 113 49 22
RAG-22/2 3 21 0
22 wt 74 88 28
NF-ATc2/2 80 68 38
Ð, not done.
(IgM), and IgD surface markers (Figure 2C) as well as of IL-2Ra (CD25) on LN cells was modestly diminished in
major histocompatibility (MHC) class II and B7.2 expres- NF-ATc±deficient T cells as compared to wt, consistent
sion (data not shown) on NF-ATc±deficient B cells, al- with the hypoactivation observed (data not shown).
though the expression of CD43 on bone marrow±derived Although NF-ATc±deficient T cells exhibited an im-
cells was increased, consistent with delayed generation paired primary proliferative response to anti-CD3, they
of the B cell pool (Figure 2D) . These data demonstrate could be propagated in culture by restimulation with
that NF-ATc is not required for the generation and basal plate-bound anti-CD3, with no reproducible proliferative
activation status of T and B lineage cells, although quan- defects when compared to wt cells (not shown). In all
titatively, their production is impaired in its absence. mice examined, however, levels of IL-2 in restimulated
NF-ATc T cell cultures were substantially increased, es-
Impaired Proliferation and IL-4 Production pecially in LN T cells (Figure 3B). In contrast, a marked
in NF-ATc2/2RAG-22/2 T Cells deficiency in the secretion of IL-4 was apparent in NF-
To test the function of NF-ATc in T lymphocyte activa- ATc2/2 spleen T cells from three of four animals upon
tion, splenic and LN cells were isolated from NF- restimulation with anti-CD3 antibody (Figure 3B). The
ATc2/2RAG-22/2 chimeras, control wt and RAG-22/2 impairment in production of IL-4 was more striking in
mice and cultured with varying doses of anti-CD3 anti- LN than in spleen (an approximately 90% decrease). It
body. The proliferation of NF-ATc±deficient spleen and
should be noted that we observed some variability in
LN cells, as measured by [3H]thymidine incorporation
the phenotype that correlated with the degree of chime-
at 48±60 hr, was modestly but consistently diminished
rism, as assessed by Southern blot analysis. In one
(Figure 3A). Inhibition of the calcineurin-mediated de-
mouse (mouse 2) with relatively poor chimerism, thephosphorylation and nuclear translocation of NF-AT by
production of IL-4 in vitro was normal; however, a sub-the immunosuppressive drugs CsA and tacrolimus
stantial shift in isotypes in this animal was still observed(FK506) results in inhibition of T and B cell proliferation
(see below and Table 2). In comparing the relativeand cytokine secretion (Emmel et al., 1989; Kubo et al.,
amounts of the two cytokines, IL-2 and IL-4, known to1994; Beals et al., 1997). The proliferation of NF-ATc null
be NF-AT dependent, a shift in the ratio of Th1 (IL-2) toT cells was inhibited by the addition of CsA, demonstra-
Th2 (IL-4) cells was observed (Figure 3B), demonstratingting that, as for NF-ATp (Hodge et al., 1996), calcineurin-
impaired generation of the Th2 cell compartment in themediated events can be mediated by proteins other
absence of NF-ATc. These data are consistent with thethan NF-ATc (Figure 3A). Consistent with the modestly
previously demonstrated in vitro effect of NF-AT in regu-diminished proliferative response, the production of
lating the transcription of the IL-4 gene (Szabo et al.,both IL-2 at 24 hr and IFNg at 48 hr by NF-ATc±deficient
1993; Rooney et al., 1994; Rooney et al., 1995a) andspleen cells was modestly (IL-2) or minimally (IFNg) de-
demonstrate a critical and nonredundant function forcreased. Levels of IL-2 and IFNg were on average 68%
NF-ATc in IL-4 production. Levels of IFNg, a cytokineand 83% of wt levels, respectively. A more substantial
not demonstrated to be highly NF-AT dependent, weredecrease in the production of both of these cytokines
normal or only modestly decreased with the exceptionwas observed in NF-ATc2/2 LN cells (IL-2 and IFNg on
average 41% and 36% of wt respectively). The induction of one animal with a substantial reduction.
Phenotype of NF-ATc±Deficient Lymphoid Chimeras
129
Figure 2. Flow Cytometric Analysis of Lymphocytes from NF-
ATc2/2RAG-22/2 Chimeric Mice
Lymphocytes from thymus (A), spleen and LN (B and C), and bone
marrow (D) of RAG-22/2, NF-ATc1/1 (129), and NF-ATc2/2RAG-22/2
mice were stained with the phycoerythrin- or fluorescein isothiocya-
nate±conjugated mAbs indicated. Results from spleen and LN are
representative of seven mice in each group, aged 10±22 weeks. In
(C), IgM and IgD expression on splenocytes was analyzed by gating
on B2201 cells.
Modest B Cell Hypoproliferation in spleens of irradiated hosts repopulated 14 weeks earlier
with either NF-ATc 1/1, 1/2, or 2/2 fetal liver cells,NF-ATc2/2RAG-22/2 Lymphoid Chimeras
and NF-ATc2/2 Fetal Liver Chimeras consistent with the findings in the older animals in the
RAG-22/2 blastocyst model described above. Mice re-NF-ATc is present at high levels in B cells (Verweij et
al., 1990). To test B cell function, spleen cells from con- populated with control RAG-22/2 bone marrow had no
mature B cells, as expected. However, as in the previoustrol or NF-ATc±deficient chimeric mice were treated with
anti-CD40 antibody in the presence or absence of re- experiment, the NF-ATc2/2 spleen cells proliferated
poorly to anti-CD40 ligation, and this proliferation wascombinant IL-4 (rIL-4). As shown in the representative
experiment in Figure 4A, proliferative responses of NF- increased by addition of rIL-4 (Figure 4B). Interestingly,
repopulation with 1/2 fetal liver resulted in an intermedi-ATc±deficient B lymphocytes to anti-CD40 were repro-
ducibly diminished (30%±70%) but could be partially or ate phenotype, consistent with a gene dosage effect.
completely restored by the addition of rIL-4. The B cell
proliferative defect was also observed in a fetal liver
chimera produced by repopulating irradiated wt mice Impaired IgG1 and IgE Production with Increased
IgM and IgG2a Production inwith fetal liver cells obtained from E14.5 NF-ATc 1/1,
1/2, or 1/2 embryos. The infusion was supplemented NF-ATc2/2RAG-22/2 Chimeras
To assess further the functional consequences of NF-with bone marrow cells from RAG-22/2 mice. In this
experiment, normal numbers of B cells were present in ATc deficiency in B cells, we analyzed the production
Immunity
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Figure 3. T Cell Proliferation and Cytokine Production in NF-ATc2/2RAG-22/2 Mice
(A) Primary proliferative responses of splenocytes and LN cells from control and chimeric mice. [3H]Thymidine incorporation at 48±60 hr by
control (1/1) and NF-ATc2/2RAG-22/2 splenocytes and LN cells in response to plate-bound anti-CD3 antibody in the presence or absence
of CsA (1 mg/ml). Data from one representative pair of mice of six pairs tested are shown. KO, knockout.
(B) Cytokine production as measured by ELISA of restimulated splenic or LN T cells from control 1/1 and NF-ATc2/2RAG-22/2 mice. Stippled
bar, wt; solid bar, 2/2. Production of IL-2 was quantitated at 24 hr and of IL-4 at 48 hr. Mouse numbers correspond to those in Table 2.
of immunoglobulin both in vivo and in vitro in the NF- mice revealed a 10-fold shift. The same pattern of selec-
tive IgG1 and IgE deficiency was observed in cultureATc2/2RAG-22/2 chimeras. Sera from nonimmunized
NF-ATc±deficient chimeras displayed a strikingly abnor- supernatants from spleen cells stimulated in vitro for 2
days with lipopolysaccharide (LPS) or anti-CD40 (Figuremal profile of immunoglobulin isotypes characterized by
a modest increase in production of IgM, IgG2a, and IgA 4C). In vitro stimulation with anti-CD40 in the presence
of rIL-4 and IL-5 resulted in restoration of IgG1 produc-and a marked decrease in IgG1 and IgE (Table 2). Levels
of IgG2b and G3 were equivalent to wt or slightly de- tion to wt levels (data not shown), suggesting that the
failure of NF-ATc±deficient mice to produce IgG1 andcreased. There was an excellent correlation between
cytokines produced in vitro by T cells and the profile of IgE was the result of deficient IL-4 production.
These data demonstrate a role for NF-ATc in B cellisotypes produced. Thus, the only chimeric animal that
had substantially decreased levels of IFNg upon a sec- activation and in IL-4±dependent differentiation, as as-
sessed by impaired proliferation and failure of switchondary stimulation (mouse 5) was also the only animal
that had diminished levels of IgG2a, an IFNg-driven iso- recombination to the IL-4±driven IgG1 and IgE isotypes
(Snapper and Paul, 1987; Snapper et al., 1988). It istype (Snapper and Paul, 1987), and the only chimeric
animal whose T cells produced normal amounts of IL-4 intriguing in this regard that NF-ATc is the NF-AT family
member expressed at the highest levels in B lympho-(mouse 2) had normal levels of IgG1. Therefore, in all
animals examined, low levels of IgG1 and IgE correlated cytes (Verweij et al., 1990). Indeed, a role for NF-AT
proteins in gene regulation in B cells has been positedwith deficiency in T cell production of IL-4. A compari-
son of the ratio of IgG2a to IgG1 (IFNg versus IL-4 depen- from studies in which ligation of B cell surface molecules
by signaling through surface immunoglobulin and CD40dent isotypes) in wt (ratio 4.7) and mutant (ratio 51.6)
Table 2. Serum Immunoglobulin Levels from wt and NF-ATc±Deficient Mice
Serum Immunoglobulin (mg/ml)
Mouse Ratio
Genotype Number Age (weeks) IgM IgG1 IgG2a IgG2b IgG3 IgA IgE (ng/ml) IgG2a/IgG1
wt 1 11 180 444 2270 159 73 156 1409 5.1
wt 2 12 225 244 713 152 142 232 1794 2.9
wt 3 14 361 3000 2780 803 200 128 8703 0.9
wt 4 17 274 580 3760 151 147 231 7200 6.5
wt 5 22 331 1973 16,280 1160 456 146 9935 8.2
NF-ATc2/2 1 11 577 84 9651 289 85 277 359 114.9
NF-ATc2/2 2 12 534 339 15,046 1339 138 589 975 44.4
NF-ATc2/2 3 14 600 276 2800 264 184 299 1247 10.1
NF-ATc2/2 4 17 499 200 12,110 200 73 303 1100 60.6
NF-ATc2/2 5 22 451 350 9780 228 78 276 198 27.9
Serum immunoglobulin levels were determined by isotype-specific ELISA in 11- to 22-week-old NF-ATc±deficient or wt mice.
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Figure 4. B Cell Proliferation and Immunoglobulin Production in NF-ATc2/2RAG-22/2 Chimeras
(A) Proliferation of splenocytes from NF-ATc2/2RAG-22/2 chimeras. [3H]Thymidine incorporation (counts per minute) by control (1/1) and
RAG-22/2 splenocytes or NF-ATc2/2RAG-22/2 chimeric splenocytes in response to plate-bound anti-CD40 antibodies in the presence or
absence of 100 U/ml recombinant IL-4. Data from one representative experiment of five are shown.
(B) Proliferation of splenocytes from fetal liver chimeras. [3H]Thymidine incorporation by control splenocytes (1/1 and 1/2 fetal liver into
irradiated host) or NF-ATc±deficient splenocytes (2/2 fetal liver into irradiated host) in response to plate-bound anti-CD40 antibodies in the
presence or absence of rIL-4 (100 U/ml). The genotype in the key refers to the genotype of the donor fetal liver cells.
(C) Levels of immunoglobulin in 2 day culture supernatants from LPS (20 mg/ml)± and anti-CD40 (10 mg/ml)±stimulated splenocytes from NF-
ATc2/2RAG-22/2 or wt mice.
receptors resulted in activation of NF-AT multimer- to and transactivate the promoters of multiple cytokine
genes in vitro, it is of interest that there is clearly cyto-reporter constructs (Choi et al., 1994; Venkataraman et
al., 1994). The identity of the endogeneous NF-AT target kine-specific regulation by NF-ATc in vivo.
The increased levels of IL-2 and normal productiongenes in B cells, however, remains to be discovered.
Since the surface expression of MHC class II, B7.1, and of tumor necrosis factor a (data not shown) observed
in a secondary response were unexpected given previ-B7.2 antigens in NF-ATc2/2 B cells is increased appro-
priately afteranti-IgM or IL-4 activation (data not shown), ous in vitro data (Rao et al., 1997). Other NF-AT family
members might compensate for the loss of NF-ATc inthe genes encoding these molecules are unlikely candi-
dates for NF-ATc±regulated genes. regulating these cytokines, as suggested by the pheno-
type of the NF-ATp±deficient mice, or transcription fac-A comparison of the phenotypes of the NF-ATp and
NF-ATc null mice is of interest. In NF-ATp±deficient ani- tors other than NF-AT may be important. Recently, a
role for the c-Rel transcription factor in T cell prolifera-mals, preferential formation of Th2 cells with increased
production of IL-4 and IgE antibody is observed (Hodge tion and IL-2 cytokine gene transcription has been pos-
ited from both in vitro (Himes et al., 1996; Wang et al.,et al., 1996; Xanthoudakis et al., 1996), whereas the
opposite phenotype, impaired production of IL-4 and 1997) and in vivo (KoÈ ntgen et al., 1995; Gerondakis et
al., 1996) studies. In the former, c-Rel was shown toIgE, is present in theNF-ATc null animals. In a secondary
immune response, the production of the Th1 cytokines bind to NF-AT sites in the IL-2 promoter and to transacti-
vate IL-2 reporter constructs. In the latter, a severe de-IL-2 and IFNg from NF-ATp null T cells is strikingly dimin-
ished (A. R., unpublished data) while IL-2 production is fect in T and B cell proliferation and in the secretion of
IL-2, IL-3, and GM-CSF was apparent in mice lackingconsistently increased and levels of IFNg only modestly
diminished compared to IL-4 in NF-ATc null T cells. c-Rel. The phenotype of the NF-ATc2/2RAG-22/2 mice
described here differs from that reported for mice lack-Taken together these data suggest that NF-AT family
members do indeed have cytokine-selective functions ing c-Rel since the latter have a more global defect in
cytokine production and fail to produce both IgG1 andthat are complementary. Since NF-AT proteins can bind
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59-TGGTGTAATAAAATTTTCCAATGTAAA-39 (-88 to 261), or withIgG2a isotypes, while the NF-ATc±deficient mice have
a control probe to confirm integrity of the extract. For supershifta selectivedefect in IL-4 production and IL-4±dependent
experiments, the extract probe mixture was then incubated with 1isotypes. It is possible that c-Rel and NF-AT proteins
ml of 7A6 antibody at a 1:10 dilution for 20 min on ice. To make
act in concert to regulate cytokine gene transcription the recombinant NF-ATc polypeptides, the wt and mutant NF-ATc
and T cell activation, with somewhat selective but over- proteins were cloned into the expression vector TP-306, which con-
tains a T7 RNA polymerase promoter. The contructs contained thelapping roles. For example, c-Rel cannot substitute for
amino-terminal portion (amino acids 408±527) of the human NF-ATcNF-AT in transactivating the IL-4 promoter or in produc-
Rel domain and the carboxy-terminal region of either the wt (aminoing endogeneous IL-4 (L. H. G., unpublished data) but
acids 528±697) or mutant murine NF-ATc. The mutant NF-ATc en-appears to be critical for IL-2 production. Experiments
codes a truncated Rel domain that is missing residues downstream
involving the production and characterization of mice of amino acid634. The proteins were expressedby in vitro transcrip-
deficient in both c-Rel and NF-AT family members by tion and translation in a reticulocyte lysate (Promega) and were
labeled with [35S]methionine. Protein expression was checked byappropriate intercrossing should prove informative.
sodium dodecyl sulfate polyacrylamide gel electrophoresis followed
by autoradiography. EMSAs were carried out as described (HoeyExperimental Procedures
et al., 1995) using an oligonucleotide containing an NF-AT binding
site from the IL-4 promoter (TACATTGGAAAATTTTATTACAC).Disruption of the NF-ATc Gene
A cDNA fragment encoding the Rel homology domain of the NF-
ATc gene was used as a probe to isolate clones from a 129/Sv Flow Cytometric Analysis
genomic library. A 2 kb fragment from the NF-ATc genomic clone Single-cell suspensions were incubated at 48C with fluorescein-
was replaced with a thymidine kinase promoter±neo±poly(A) cas- or phycoerythrin-conjugated antibodies (Pharmingen) and analyzed
sette from pMC1neopoly(A) (Stratagene). The replacement cassette using a FACScan (Becton Dickenson) with Cell Quest software. The
was prepared by transferring a PstI-to-NdeI fragment containing following antibodies were used: anti-CD3 (145±2C11), anti-CD4
approximately 6 kb of 59 NF-ATc sequence, the neo cassette, and (RM4±4), anti-CD8a (53±6.7), anti-CD45R/B220 (RA3±6B2), anti-
2 kb of 39 NF-ATc sequence, to a plasmid encoding the thymidine IgDa (AMS9.1), anti-IgMa (DS-1), and anti-CD43 (S7). The rat anti-
kinase drug-resistance gene. D3 ES cell clones transfected with the mouse FcRgII/III mAb (2.4G2) was used to block nonspecific binding.
targeting construct were selected for drug resistance in 180 mg/ml
G418 and 2 mM gancyclovir. Screening for homologous recombi-
nants was performed by digesting genomic DNA from drug-resistant Analysis of Cell Activation
clones. For T cell proliferation, 2 3 105 spleen or LN cells from control 1/1
One such clone, 141, was then transfected with a second targeting mice, NF-ATc2/2RAG-22/2 chimeras, or BALB/c mice repopulated
construct identical to the first except for the replacement of the neo with NF-ATc 1/1, 1/2, or 2/2 fetal liver were incubated per well
drug-resistance gene with the hygro drug resistance gene, and ES of a 96-well plate previously coated with anti CD3e antibody (0.1±10
clones were selected for drug resistance in 400 mg/ml hygromycin mg/ml). Cultures were pulsed at 48 hr with 1 mCi of [3H]thymidine
B and 2 mM gancyclovir. One clone bearing disruptions of both NF- (New England Nuclear) and harvested 12 hr later. For analysis of B
ATc alleles was identified by digesting genomic DNA with BamHI cell proliferation, plates were coated with 10 mg/ml anti-CD40 anti-
and hybridizing with the 0.8 kb Asp718/BamHI 39 probe, yielding body (Pharmingen) with or without rIL-4 (Genzyme) at 100 U/ml. LPS
two fragments of 8.5 and 7.9 kb (neo and hygro respectively). Two (Sigma) was used at 20 mg/ml. To measure B cell immunoglobulin
subclones were injected into RAG-22/2 blastocysts as described isotype switching, cells were cultured at 2 3 106/ml in 24-well plates
(Chen et al., 1993), but only one of the subclones yielded highly for 6 days with anti-CD40 antibody plus rIL-4 (400 U/ml) and rIL-5
chimeric mice. (500 U/ml) or LPS as above. To analyze proliferation and cytokine
secretion of primed splenic or LN T cells, cells were removed from
Production of NF-ATc2/2 Fetal Liver Chimeras anti-CD3e±coated plates at 48 hr, maintained for 7±10 days in media
An ES clone with a disruption in one NF-ATc allele generated chime- containing human IL-2 as previously described (Hodge et al., 1996),
ras that transmitted to the germline (Ranger et al., 1997). Homozy- and restimulated at 105 cells/well with plate-bound anti-CD3 in the
gous (2/2) mice died in utero as a result of cardiac failure (Ranger absence of IL-2. Proliferation was assayed as described above. All
et al., 1997). However, approximately 70% of the 2/2 embryos assays were conducted in triplicate.
survived until E14.5, thus allowingthe production of fetal liver chime-
ras. To produce fetal liver chimeras, 10±15 3 106 liver cells (an entire
Measurement of Cytokine and Antibody Levelsliver) from E14.5 1/1, 1/2, and 2/2 embryos were mixed with 5±10
by Enzyme-Linked Immunosorbent Assay3 106 RAG-22/2 bone marrow cells or RAG-22/2 bone marrow alone
Supernatants from the cultures described above were assayed foras a control and transferred into 900 rad irradiated BALB/c hosts.
levels of IL-2, IL-4, and IFNg by enzyme-linked immunosorbentChimeras were analyzed 14 weeks after repopulation.
assay (ELISA) (Pharmingen) as previously described (Hodge et al.,
1996). Chimeric mice were bled by cardiac puncture and the seraWestern Blot and EMSA Analysis
analyzed for immunoglobulin isotypesas previously described (Mar-of NF-ATc Polypeptides
kowitz et al., 1993).Nuclear extracts for Western blot analysis were prepared from wt
(129) and NF-ATc2/2RAG-22/2 splenocytes that had been stimulated
in vitro with plate-bound anti-CD3 for 2 days, cultured with human Acknowledgments
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